Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 2/20 | 0.46 |
| ▸ | DNM1 | Q05193 | 9/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.37 |
| ▸ | F13A1 | P00488 | 1/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | CA3 | P07451 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | THPO | P40225 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8380351 | 0.91 | EPHX1 (0.39) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL1408947 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL1408879 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL15283367 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL34358 | 0.83 | — | — | |
| SCHEMBL8502653 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL487567 | 0.83 | — | — | |
| SCHEMBL1408762 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL6230952 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A | |
| SCHEMBL1408882 | 0.83 | EPHX1 (0.55) | EPHX1DNM1TSHRMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 263 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4700098-A1 | HIGH-SOLIDS TRIGLYCERIDE OIL BASED WOOD COATING COMPOSITIONS | SPSV B.V. (NL) | 2026-02-25 | — | — | EP | claimed |
| US-20240299730-A1 | POLYMER COATINGS FOR SHAPE MEMORY ALLOYS FOR USE IN PERCUTANEOUS HEART PUMPS | TC1 LLC | 2024-09-12 | — | — | US | claimed |
| US-12017056-B2 | Polymer coatings for shape memory alloys for use in percutaneous heart pumps | TC1 LLC (US) | 2024-06-25 | — | — | US | claimed |
| US-11242478-B2 | Charged composite materials, methods of synthesizing, and methods of use | SAUDI ARABIAN OIL COMPANY (SA) | 2022-02-08 | — | — | US | claimed |
| EP-3850053-A1 | CHARGED COMPOSITE MATERIALS, METHODS OF SYNTHESIZING, AND METHODS OF USE | Saudi Arabian Oil Company (SA) | 2021-07-21 | — | — | EP | claimed |
| US-20210162200-A1 | POLYMER COATINGS FOR SHAPE MEMORY ALLOYS FOR USE IN PERCUTANEOUS HEART PUMPS | TC1 LLC (US) | 2021-06-03 | — | — | US | claimed |
| EP-3775317-A1 | POLYMER COATINGS FOR SHAPE MEMORY ALLOYS FOR USE IN PERCUTANEOUS HEART PUMPS | TC1 LLC (US) | 2021-02-17 | — | — | EP | claimed |
| WO-2020056087-A1 | CHARGED COMPOSITE MATERIALS, METHODS OF SYNTHESIZING, AND METHODS OF USE | SAUDI ARABIAN OIL COMPANY (SA) | 2020-03-19 | — | — | WO | claimed |
| US-20200087559-A1 | CHARGED COMPOSITE MATERIALS, METHODS OF SYNTHESIZING, AND METHODS OF USE | SAUDI ARABIAN OIL COMPANY (SA) | 2020-03-19 | — | — | US | claimed |
| WO-2019194956-A1 | POLYMER COATINGS FOR SHAPE MEMORY ALLOYS FOR USE IN PERCUTANEOUS HEART PUMPS | TC1 LLC (US) | 2019-10-10 | — | — | WO | claimed |
| EP-2100936-A2 | Use of silane promoter to modify pressure sensitive adhesive for use in pressure seal mailers printed on igen3 | Xerox Corporation (US) | 2009-09-16 | — | — | EP | claimed |
| US-20090214618-A1 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL | 2009-08-27 | — | — | US | claimed |
| US-7579394-B2 | Adhesion promoter | XEROX CORPORATION (US) | 2009-08-25 | — | — | US | claimed |
| US-20090184157-A1 | USE OF SILANE PROMOTER TO MODIFY PRESSURE SENSITIVE ADHESIVE FOR USE IN PRESSURE SEAL MAILERS PRINTED ON IGEN3 | XEROX CORPORATION | 2009-07-23 | — | — | US | claimed |
| US-20080274420-A1 | ADHESION PROMOTER | XEROX CORPORATION (US) | 2008-11-06 | — | — | US | claimed |
| US-20080171826-A1 | ADHESION PROMOTER | XEROX CORPORATION (US) | 2008-07-17 | — | — | US | claimed |
| US-20080171199-A1 | ADHESION PROMOTER | XEROX CORPORATION (US) | 2008-07-17 | — | — | US | claimed |
| US-20080071043-A1 | ADHESION PROMOTER | XEROX CORPORATION (US) | 2008-03-20 | — | — | US | claimed |
| US-20060246239-A1 | Porous inkjet recording material | HEWLETT-PACKARD DEVELOPMENT COMPANY, L.P. | 2006-11-02 | — | — | US | claimed |
| US-20060134339-A1 | Coating compositions and methods of making and using them | CHEMETALL CORPORATION | 2006-06-22 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090214618-A1 | Nitric oxide-releasing particles for nitric oxide therapeutics and biomedical applications | NOS2, NOS3, NOS1 | EPHX1 1648/4885DNM1 1917/4885TSHR 673/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.